Erin McMenamin on Head and Neck Cancer Treatments

Video

Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative head and neck cancers.

Erin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative disease.

McMenamin says treatment options for HPV-positive head and neck cancers include similar treatments to other head and neck cancers. Patients may undergo surgical resection. More commonly today, patients may have TransOral Robotic Surgery (TORS). These newer surgeries prevent the deformities caused by older treatments.

Depending on the stage of disease, patients may receive radiation postoperatively as well as chemotherapy. These treatments depend on the stage of disease and whether there is node involvement. Chemotherapy tends to be cisplatin-based, just as would be seen with an HPV-negative tumor.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD